PF04929113

Description: PF04929113 (SNX-5422) is a synthetic, novel, small molecule Hsp90 Inhibitor. As an oral formulation that demonstrates strong efficacy and tolerability, PF04929113 is positioned as a breakthrough therapy with broad applicability across a wide range of cancers. Target: HSP, HER. Smiles: C(F)(F)(F)C=1C2=C(N(N1)C3=CC(N[C@@H]4CC[C@@H](OC(CN)=O)CC4)=C(C(N)=O)C=C3)CC(C)(C)CC2=O. References: Huang KH, et al, J Med Chem, 2009, 52(14), 4288-4305